Please enable JS

Next CRO

NEXT CRO runs clinical trials in Greece, Türkiye and Cyprus, and with its worldwide alliances, offering “plug and play” Study Teams.

 

NEXT CRO is committed to deliver high quality Clinical Trial Services to its customers, meeting high sponsor’s expectations on faster start-up timelines, specific KPIs, and dedicated teams that are accountable to their assignments.

 

Learn more: www.nextcro.eu

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Join Telemedicine Technologies at EUCROF25!

December 19, 2024

2-4 February 2025 – Copenhagen | Booth 21 We’re thrilled to showcase CleanWeb™, our advanced eClinical Suite for managing Clinical Trials, Registries, and Managed Access Programs. With 20+ integrated modules, CleanWeb™ simplifies research and drives innovation. Meet our team and discover how we can support your upcoming clinical projects. Alongside our CRO Alliance partners (CERC, […]

READ MORE
telemedecine technologies news

UK Announces New Research Hubs to Boost Clinical Trials and Advanced Treatments: The Southampton Hub

December 19, 2024

Trial Site News The United Kingdom (UK) government has announced a £100 million public-private investment to establish 20 research/trial site hubs across the country, a move aimed at bolstering clinical trials and advancing treatment access. This initiative, part of the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme, is a collaboration between the […]

READ MORE
telemedecine technologies news

How Large Language Models Will Improve the Patient Experience

December 19, 2024

Med City News LLMs bring great potential to help the healthcare industry center care around patients’ needs by improving communication, access, and engagement. However, LLMs also present significant challenges associated with privacy and bias that also must be considered. Large language models (LLMs) have generated buzz in the medical industry for their ability to pass […]

READ MORE